Compare Kohl's Corporation (KSS) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kohl's Corporation vs Regeneron Pharmaceuticals Inc — how do they compare? Kohl's Corporation trades at $18.7 (market cap $2.10B), while Regeneron Pharmaceuticals Inc trades at $794.9 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 39.1× Kohl's Corporation's market cap, and Kohl's Corporation pays the higher dividend (2.7%). Which is the better fit depends on your goals.
| KSS | REGN | |
|---|---|---|
Market Cap | $2.10B | $82.06B |
Sector | Consumer Cyclical | Health |
52-Week High | $24.71 | $812.27 |
52-Week Low | $11.72 | $555.51 |
Enterprise Value | $8.20B | $76.77B |
Dividend Yield | 2.7% | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Kohl's Corporation
Kohl's operates 1,165 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also operates a large digital sales business. Women's apparel is Kohl's largest category, having generated 27% of its 2021 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.
Read more on KSS →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
